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Mesopontine cholinergic inputs to midbrain
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Stressful life events are primary environmental factors that markedly contribute to depression
by triggering brain cellular maladaptations. Dysregulation of ventral tegmental area (VTA)
dopamine neurons has been causally linked to the appearance of social withdrawal and
anhedonia, two classical manifestations of depression. However, the relevant inputs that
shape these dopamine signals remain largely unknown. We demonstrate that chronic social
defeat (CSD) stress, a preclinical paradigm of depression, causes marked hyperactivity of
laterodorsal tegmentum (LDTg) excitatory neurons that project to the VTA. Selective
chemogenetic-mediated inhibition of cholinergic LDTg neurons prevent CSD-induced VTA
DA neurons dysregulation and depressive-like behaviors. Pro-depressant outcomes are
replicated by pairing activation of LDTg cholinergic terminals in the VTA with a moderate
stress. Prevention of CSD outcomes are recapitulated by blocking corticotropin-releasing
factor receptor 1 within the LDTg. These data uncover a neuro-circuitry of depressive-like
disorders and demonstrate that stress, via a neuroendocrine signal, profoundly dysregulates
the LDTg.
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Depression is a frequently diagnosed mental condition thathas detrimental impact on psychological well-being andon health systems. It is the leading cause of disability
worldwide and the World Health Organization estimates that 350
millions of people of all ages suffer from this disorder1. Social
withdrawal and anhedonia, i.e., inability to experience pleasure
from normally rewarding actions, are conspicuous manifestations
of major depression2. These symptomatic facets of the disease
have been associated with a dysregulation of the brain reward
system, including dopamine (DA) neurons in the ventral teg-
mental area (VTA)3,4.
This system has a predominant role in processing salient sti-
muli, both rewarding and aversive, to guide a broad range of
adaptive behaviors5. DA neurons undergo experience-dependent
plasticity, which is thought to be a cardinal cellular mechanism
shaping behavioral strategies6. The use of preclinical models
spanning from rodents to non-human primates is essential to
apprehend the neurobiological complexity of depression7. For
example, mice subjected to repeated bouts of social subordination
exhibit a marked and sustained increase in the firing activity of
VTA DA neurons8–11. Defeated mice display a wide range of
depressive-like symptoms, including social aversion and anhe-
donia, which can be reversed by restoring normal VTA
function8,9. These observations set the basis for a neuroanato-
mical specificity causally linking DA cellular adaptations and
maladaptive behaviors to chronic stress. However, a clear
understanding of how cellular adaptations within delineated
neural circuits give rise to depressive-like behaviors is still largely
lacking. In particular, identifying relevant inputs that shape DA
neurons’ responsiveness to stress is essential and has important
implications for future therapeutic advances.
Among the many inputs received by VTA neurons12, excita-
tory cholinergic and glutamatergic projections from the later-
odorsal tegmentum (LDTg) are key to shape DA neurons’ activity
in response to salient stimuli13,14. Pharmacological inhibition or
excitotoxic lesions of the LDTg are detrimental to VTA DA
neurons’ activity13,15. LDTg inputs to the VTA are key to shape
reward responses14,16, but their implication in stress-related
experiences has yet to be addressed. We hypothesized that LDTg
excitatory drive to VTA DA neurons could actively orchestrate
cellular and behavioral manifestations of depressive-like beha-
viors. To test this, we combined retrograde labeling, and elec-
trophysiological and behavioral approaches to assess the impact
of a chemogenetic-based remote control of LDTg neurons’
activity in mice subjected to a chronic social defeat (CSD)
stress17,18. Our data indicate that CSD, via increase of
corticotropin-releasing factor (CRF), triggers a hyperactivity of
LDTg cholinergic neurons projecting to the VTA. This increased
cholinergic tone is a prerequisite for the subsequent stress-
induced cellular adaptations of VTA DA neurons and the
appearance of social aversion and anhedonia.
Results
Silencing LDTg prevents maladaptations to chronic stress. A
single social defeat session exerted strong activation of excitatory
LDTg neurons as evidenced by an increase in c-Fos expression, a
classical marker of neuronal activity. Indeed, more than 5-fold c-
Fos increase was detected in both cholinergic and glutamatergic
LDTg neuronal populations (Fig. 1a). To interrogate whether the
LDTg is embedded in the brain circuits that underlie the
appearance of depressive-like disorders, we used a chemogenetic
approach to remotely inhibit the LDTg before each daily defeat
session of the chronic defeat paradigm. Wild-type (WT) mice
were injected with AAV-hsyn-hM4-mcherry into the LDTg
(hereafter called LDTghM4 mice) and allowed a 3-week recovery
period to achieve sufficient expression reaching 71% of LDTg
neurons (Supplementary Fig. 1). This approach allowed silencing
of transduced LDTg neurons in the presence of the agonist clo-
zapine N-oxide (CNO) (Supplementary Fig. 2a). Acute
chemogenetic-mediated inhibition of the LDTg via CNO injec-
tion, significantly decreased spontaneous discharge frequency
(∼40%) and bursting activity (∼80%) in all VTA DA neurons
juxtacellularly recorded in vivo in anesthetized mice (Fig. 1b). Of
note, acute injection of CNO did not alter in vivo firing and
bursting activity of VTA DA neurons (Supplementary Fig. 3a, b)
in mice injected with AAV-hSyn-GFP into the LDTg (hereafter
called LDTgGFP mice). This first set of data shows that the LDTg is
activated by stress, and that its remote chemogenetic inhibition
has a functional impact on VTA DA neurons activity. Next,
LDTghM4 mice were submitted to 10 days of social defeat and
received an intraperitoneal (i.p.) injection of saline or CNO (1mg/
kg) 30min before each defeat session. Naive mice were treated
accordingly but without defeat (Fig. 1c). All animals were tested in
a drug-free condition. As expected, defeated mice treated with
saline showed strong social avoidance (Fig. 1d) and anhedonia, as
evidenced by a lack of sucrose preference compared with non-
stressed saline-treated mice (Fig. 1e). In contrast, LDTg inhibition
during CSD prevented stress impact, as defeated CNO-treated
mice showed social interaction and sucrose preference that were
comparable to that of undefeated animals (Fig. 1d, e). These effects
cannot be attributed to a direct action of CNO, as LDTgGFP mice
treated accordingly showed the expected stress-induced social
aversion and anhedonia (Supplementary Fig. 3c). As these stress-
related symptoms have been causally linked to pathophysiological
cellular maladaptations in the DA system8,9, we assessed VTA DA
neuron firing and plasticity in both conditions using whole-cell
current-clamp recordings. In acute brain slices from defeated
saline-treated mice, VTA DA neurons exhibited increased excit-
ability to current injection and higher AMPA-R/NMDA-R ratio
when compared with undefeated mice (Fig. 1f, g). Mirroring the
behavioral outcomes of LDTg inhibition, CSD failed to elicit VTA
cellular adaptations. Indeed, no significant differences were
observed in excitability or synaptic plasticity in VTA DA neurons
from defeated LDTghM4 mice treated with CNO during CSD
compared with undefeated mice (Fig. 1f, g, respectively). Of note,
chronic CNO injections in naive and defeated LDTgGFP mice did
not alter excitability of VTA DA neurons (Supplementary Fig. 3d).
Altogether, these results indicate that LDTg is activated during
chronic stress, and that LDTg inhibition prevents the development
of depressive-like behaviors and the underlying cellular dysregu-
lations of the VTA DA system.
Chronic stress drives hyperexcitability of LDTg neurons. The
LDTg is heterogeneous containing non-overlapping VTA-pro-
jecting neurons14 and converging evidence suggest that both
cholinergic and glutamatergic LDTg neurons provide excitatory
inputs to VTA DA neurons12,16,19. Thus, we hypothesized that
these excitatory projections could be affected by chronic stress
consequently leading to hyperactivity of VTA DA neurons. To
unambiguously perform whole-cell patch-clamp recordings from
cholinergic LDTg neurons that project to the VTA (LDTg→VTA),
we injected green retrobeads in the VTA of ChAT-Cre × tdTo-
mato mice (ChATtdTom mice Fig. 2a), in which cholinergic
neurons are tagged with tdTomato. To record from glutamatergic
LDTg→VTA neurons, we injected green retrobeads in the VTA
and AAV-hsyn-DIO-mcherry in the LDTg of Vglut2-Cre mice20
(Fig. 2b). Cholinergic and glutamatergic LDTg→VTA neurons
showed different excitability profile to depolarizing current steps,
as well as different soma sizes, passive membrane properties, and
action potential shape (Fig. 2c and Supplementary Fig. 4). This is
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consistent with two non-overlapping neuronal populations that
provide separate excitatory drive to midbrain DA neurons. CSD
triggered a robust increase in excitability in both cholinergic and
glutamatergic LDTg→VTA neurons. Indeed, cholinergic
LDTg→VTA neurons responded with higher discharge frequency
to depolarizing current injections in slices from defeated mice
compared with undefeated animals (Fig. 2d, e). Similarly, gluta-
matergic LDTg→VTA neurons showed higher intrinsic excitability
after CSD than undefeated mice (Fig. 2d–f). These results suggest
that CSD increases excitatory drive from LDTg cholinergic and
glutamatergic neurons that innervate the VTA, possibly driving
the cellular hyperexcitability of midbrain DA cells.
LDTg cholinergic neurons silencing dampens stress impact. To
ascertain the individual contribution of LDTg cholinergic and/or
glutamatergic neurons to depressive-like behaviors and VTA DA
dysregulations, we used a Cre-dependent chemogenetic approach
to specifically silence these neuronal populations. First, AAV-
hSyn-DIO-hM4-mcherry was stereotaxically injected in the LDTg
of ChAT-Cre mice (hereafter called LDTgChAT-hM4 mice, Fig. 3a
and Supplementary Fig. 5a). Selective inhibition of LDTg choli-
nergic neurons during CSD prevented the behavioral manifesta-
tions of stress. Indeed, although defeated LDTgChAT-hM4 mice
treated with saline showed strong social avoidance and anhedonic
responses to sucrose solution, CNO-treated LDTgChAT-hM4 mice
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displayed normal social interaction and sucrose intake (Fig. 3b
and Supplementary Fig. 5b, respectively). Behavioral responses
were comparable in undefeated LDTgChAT-hM4 mice treated with
either saline or CNO (Fig. 3b and Supplementary Fig. 5b).
Consistent with these results, selective silencing of cholinergic
LDTg neurons during CSD prevented stress-induced VTA DA
neuron hyperexcitability and increases in AMPA-R/NMDA-R
ratio (Fig. 3c and Supplementary Fig. 5c, respectively). We also
recorded cholinergic LDTg neurons from LDTgChAT-hM4 mice.
Chronic CNO administration did not affect the excitability profile
of these neurons in naive conditions when compared with saline
but prevented CSD-induced hyperexcitability (Supplementary
Fig. 5d).
In striking contrast, selective silencing of LDTg glutamatergic
neurons during CSD failed to prevent behavioral and cellular
adaptations to stress. To reach this observation, we injected AAV-
hSyn-DIO-hM4-mcherry in the LDTg of Vglut2-Cre mice (here
after LDTgVglut2-hM4 mice, Fig. 3d). Defeated LDTgVglut2-hM4
mice treated with either saline or CNO exhibited significant social
aversion (Fig. 3e) and similar hyperexcitability in VTA DA
neuron firing (Fig. 3f). Collectively, the above data indicate that
cholinergic, neurons of the LDTg are key orchestrators of
maladaptations to chronic stress impinging on VTA DA neurons
that ultimately drive social aversion and anhedonic processes.
Conversely, silencing of LDTg glutamatergic neurons did not
yield stress relief, which may reflect compensation from other
glutamatergic inputs to the VTA.
LDTg→VTA cholinergic pathway activation gates stress impact.
Due to the widespread projections of LDTg neurons, we wanted
to narrow down the observed effect to LDTg projections to the
VTA. Also, if activation of these projections is required for stress
outcomes, this would imply that increasing activity of LDTg
neurons that project to the VTA could favor stress-induced
maladaptations. This would result in an enhanced sensitivity of
the DA system to a moderate social stress, and the appearance of
social aversion. In order to selectively activate LDTg neurons that
project to the VTA, we injected a retrograde CAV-2-Cre in the
VTA and AAV-hSyn-DIO-hM3-mcherry in the LDTg of WT
mice (hereafter LDTghM3→VTA mice, Fig. 4a). This approach
allows activation of transduced LDTg neurons in the presence of
CNO (Supplementary Fig. 2b). To mimic a moderate social stress,
we submitted LDTghM3→VTA mice to a subthreshold defeat
(SubSD) paradigm (Fig. 4a). We and others have previously used
this protocol to evaluate the stress-potentiating effects of either
optogenetic or pharmacological manipulation of VTA DA
neurons9,21. We observed that SubSD triggered social aversion in
mice receiving CNO, whereas it was ineffective in saline-injected
mice. In view of our above results, we hypothesized that this effect
could be mediated by Designer Receptor Exclusively Activated by
Designer Drug (DREADD)-induced activation of cholinergic
inputs from the LDTg to the VTA, via activation of neuronal
nicotinic acetylcholine receptors (nAChRs) that are key regulators
of VTA DA neurons21,22. To test this, we locally infused the non-
selective nAChRs antagonist mecamylamine in the VTA, before
LDTghM3→VTA mice entered the SubSD protocol (Fig. 4b). This
treatment fully prevented the appearance of social aversion
resulting from a mild stress combined with DREADD activation
of the LDTg→VTA pathway (Fig. 4b). In line with the behavioral
data, LDTghM3→VTA mice submitted to SubSD showed enhanced
excitability of VTA DA neurons when injected with CNO but not
saline, an effect that could be reversed by systemic injection of
mecamylamine (Fig. 4c). This set of data indicates that direct
LDTg stimulation of VTA neurons paired with a short-lived
stress is sufficient to promote behavioral and cellular adaptations,
and that this effect requires activation of VTA nAChRs. To
unambiguously demonstrate the involvement of LDTg choliner-
gic neurons projecting to the VTA in this process, we locally
infused CNO in the VTA of LDTgChAT-hM3 mice to selectively
activate cholinergic terminals. Although vehicle-treated mice
submitted to SubSD showed normal social interaction, VTA
infusion of CNO combined with SubSD triggered significant
social aversion (Fig. 4d). Therefore, our data demonstrate that
LDTg cholinergic inputs to the VTA drive maladaptations to
social stress. It also demonstrates that we can exert a bidirectional
control over LDTg neurons to either favor or block adaptations to
stress within VTA DA neurons.
CRF signaling affect LDTg cholinergic neurons. What is the
molecular determinant of stress’ action that drives hyperexcit-
ability of cholinergic LDTg neurons? Stressors trigger the acti-
vation of the hypothalamo-pituitary adrenal axis, which is
initiated by the release of CRF, a neuropeptide that act at hypo-
thalamic and extra-hypothalamic sites23. CRF is a potent and
fast-acting mediator of endocrine and autonomic responses to
stress, and regulates neurotransmission directly through two
Fig. 1 Chemogenetic inhibition of the LDTg during chronic defeat prevents depressive-like behaviors and VTA DA cellular adaptations. a Activation of LDTg
cholinergic and glutamatergic neurons after a single defeat. Images shows LDTg c-Fos positive (c-Fos+ ) cells (scale bar= 50 µm). Quantification of LDTg
c-Fos+ cells after acute defeat stress (n= 3 slices/mouse, 4 mice/condition, **P < 0.001 unpaired t-test). b In vivo recordings were performed in the VTA
3 weeks after viral injection. While under anesthesia, mice were given intravenously saline or CNO and changes in activity from baseline assessed. In all
instances, dopamine neurons in the VTA showed a decrease in firing frequency (****P < 0.0001, t-test) and bursting activity (**P < 0.01, Mann–Whitney) in
response to CNO when compared with saline (number of cell/mice: saline n= 33/4 and CNO n= 45/5). Voltage traces are shown. c Schematic
experimental time line. d Social interaction times in the absence no target (NTg) or presence target (Tg) of an unfamiliar mouse. Defeated LDTghM4 mice
treated with saline show marked social avoidance, which is not present in animals that received CNO before each defeat session (number of mice: Naive/
Sal= 16; Naive/CNO= 16; CSD/Sal= 20; CSD/CNO= 19). Interaction treatment × target F(3,67)= 5.14, P= 0.003, Interaction treatment × stress F
(1,67)= 13.55, P < 0.001; repeated-measures two-way ANOVA followed by Sidak’s comparisons test, asterisks depict NTg vs. Tg comparisons, hash
depicts comparisons between saline vs. CNO in the Tg condition; ***P < 0.001, ###P < 0.001. e Sucrose consumption is decreased in defeated saline-
treated LDTghM4 mice but not in CNO-treated mice (number of mice: Naive/Sal= 23; Naive/CNO= 18; CSD/Sal= 16; CSD/CNO= 15). Interaction
treatment × stress F(1,66)= 5.39, P= 0.02; two-way ANOVA followed by Sidak’s comparisons test ***P < 0.001. f Chemogenetic inhibition of the LDTg in
defeated LDTghM4 mice prevents the apparition of VTA DA hyperexcitability (number of cell/mice: Naive/Sal= 21/5; Naive/CNO= 12/4; CSD/Sal= 20/
5; CSD/CNO= 18/5). Interaction treatment × current F(18,384)= 2.39, P= 0.001; repeated-measures two-way ANOVA followed by Sidak’s comparisons
test ***P < 0.001. Representative voltage traces are shown. g Increase in VTA DA AMPA-R/NMDA-R ratio after CSD is prevented by chemogenetic
inhibition of LDTg (number of cell/mice: Naive/Sal= 10/5; Naive/CNO= 10/5; CSD/Sal= 8/6; CSD/CNO= 9/6). Interaction treatment × stress
F(1,33)= 4.12, P < 0.05; two-way ANOVA followed by Sidak’s comparisons test ***P < 0.001. Representative current traces in the absence/presence of the
NMDA antagonist AP-5. All plots depict mean ± SEM
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Fig. 2 Cholinergic and glutamatergic LDTg→VTA neurons are sensitive to chronic stress. a ChAT-Cre::tdTomato mice were injected with green retrobeads
in the VTA. Confocal images show the co-expression of green beads and tdTomato in cholinergic neurons of the LDTg. b Vglut2-Cre mice were injected
with an AAV8-hSyn-DIO-mcherry in the LDTg and green retrobeads in the VTA. Confocal images show the co-expression of green beads and mcherry in
glutamatergic neurons of the LDTg. c Bioelectrical properties of cholinergic and glutamatergic LDTg→VTA neurons. Cholinergic neurons show bigger
capacitance and lower firing frequencies at each current step injection (number of cell/mice: ChAT+= 15/4; Vglut+= 14/3). Interaction cell type ×
current F(6, 162)= 15.77, P < 0.0001; repeated-measures two-way ANOVA followed by Sidak’s comparisons test ***P < 0.001. Representative voltage
traces showing response to current injection (− 40 and + 60 pA) in both neuronal populations. d Schematic experimental time line to assess excitability in
cholinergic and glutamatergic neurons after CSD. e Patch-clamp recordings in cholinergic LDTg→VTA neurons revealed increased excitability after CSD
(number of cell/mice: ChAT+ /Naive= 15/3; ChAT+ /CSD= 15/4). Interaction treatment × current F(6, 168)= 19.23, P= 0.0001; repeated-measures
two-way ANOVA followed by Sidak’s comparisons test ***P < 0.001. Representative voltage traces to a 300 pA current injection. f Patch-clamp recordings
in glutamatergic LDTg→VTA neurons also shows increased excitability after CSD (number of cell/mice: Vglut+ /Naive= 13/4; Vglut/CSD= 9/4).
Interaction treatment × current F(18, 384)= 2.39, P= 0.001; repeated-measures two-way ANOVA followed by Sidak’s comparisons test, **P < 0.01.
Representative voltage traces to a 50 pA current injection. All plots depict mean ± SEM
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receptor subtypes, CRF receptor 1 (CRF-R1) and CRF-R223. It is
therefore possible that the CRF system has a role in social stress
processing in the LDTg consequently affecting its output con-
nectivity. A single defeat session in naive mice led to a significant
increase (1.8-fold) in plasma CRF levels (basal, 399.9 ± 116.7 pg/
ml; acute aggression, 723.5 ± 178.6 pg/ml; n= 8–12 per group, P
< 0.05, Mann–Whitney). To ascertain the functional role of
stress-induced CRF release onto LDTg cholinergic neurons, and
the respective contribution of CRF-1 or CRF-2 receptor subtypes,
we performed whole-cell patch-clamp recordings in slices from
ChATtdTom mice (Fig. 5a). In current-clamp mode and after
reaching a stable baseline, the CRF-R1 agonist stressin I (1 µM) or
the CRF-R2 agonist urocortin III (1 µM) were applied to the
perfusion system. Stressin I application, but not urocortin III,
consistently initiated action potential discharge in all cholinergic
neurons tested, and this effect disappeared after washout of the
drug (Fig. 5a). In contrast, stressin I and urocortin III failed to
elicit any notable responses in LDTg glutamatergic neurons
(Fig. 5b). To further refute the involvement of CRF-R1, a subset
of LDTg glutamatergic neurons were depolarized to − 55 mV by
current injection before applying the agonist. Even in this con-
dition, stressin I failed to initiate action potential firing (five cells
from two mice). These data suggest that after CSD, cholinergic
neurons of the LDTg could be overly activated by the release of
CRF via activation of excitatory CRF-R1. To answer this question,
WT mice were subjected to CSD where each defeat session was
preceded by a local bilateral injection of a CRF-R1-specific
antagonist, CP376395 (500 ng/site), or saline. Control mice
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received the same treatment but without defeat (Fig. 5b) and
animals were tested in drug-free conditions. Chronic infusion of
CP376395 did not affect social approach or sucrose preference in
undefeated mice; however, CP376395 fully prevented the
appearance of stress-induced social aversion and anhedonia
(Fig. 5c, d). We then assessed the state of VTA DA neuron
excitability and, in accordance with the behavioral results, local
CP376395 infusion in the LDTg prevented hyperexcitability
induced by CSD (Fig. 5e). This demonstrates the ability of CRF
signaling in the LDTg to promote depressive-like behaviors via
dysregulation of VTA DA function.
Discussion
Here we demonstrated that chronic social stress exposure pro-
duces profound dysregulation of excitatory inputs from the LDTg
to the VTA via CRF signaling. Selective inhibition of cholinergic,
but not glutamatergic, LDTg neurons prevents stress-induced
cellular adaptations within VTA DA neurons and the appearance
of anhedonia and social withdrawal.
Central cholinergic neurotransmission is a powerful neuromo-
dulator that, in physiological conditions, affects neuronal excit-
ability and synaptic strength to synchronize neuronal networks, in
order to guide adaptive behaviors24,25. Dysregulation of acet-
ylcholine tone in discrete brain areas can lead to pathophysiolo-
gical states26,27, and in particular a heightened cholinergic
transmission has long been postulated to contribute to depres-
sion28. This hypothesis is supported by the observations that
depressive symptomatology can be induced by cholinomimetics or
inhibition of acetylcholinesterase29–31. Despite this evidence, the
neuronal circuit underlying depression, as well as the cellular and
synaptic changes driven by acetylcholine, are still poorly under-
stood. Our data uncover a cardinal role of cholinergic neurons of
the LDTg in the appearance of chronic stress-induced depressive-
like behavioral manifestations. We show that CSD increased the
excitability of LDTg cholinergic neurons that project to the VTA.
Increased cholinergic tone would favor DA neurons firing by two
mechanisms. Activation of excitatory postsynaptic nAChRs pro-
duces depolarization and firing activity of DA neurons32. In
addition to direct activation, acetylcholine release can enhance the
release of glutamate from other inputs via activation of pre-
synaptic nAChRs33,34 (Fig. 6). We put in evidence the importance
of this cholinergic/nicotinic mechanism by pharmacological
blockade of VTA nAChRs. This is in line with our previous data
showing that constitutive ablation of nAChRs is sufficient to
prevent CSD-induced hyperactivity of DA neurons21.
Although the mechanisms underlying CSD-induced increases
in DA firing are at present unclear, our study suggests that
adaptations in both intrinsic and synaptic plasticity could con-
tribute to this process35. For example, we showed that CSD
induces changes in AMPA-R/NMDA-R ratio, a proxy for gluta-
matergic synaptic strength. Our data suggest that cholinergic
LDTg inputs may serve as a permissive signal. Indeed, silencing of
the LDTg cholinergic pathway was effective in preventing stress-
induced changes in activity and glutamatergic plasticity of DA
neurons. Unlike cholinergic neurons, silencing of LDTg gluta-
matergic neurons did not produce stress relief. This may be
explained by the fact that the VTA receives numerous sources of
glutamatergic inputs12,36, which have been shown to be
strengthened by aversive stimuli37. It is evident that the gluta-
matergic synapse undergoes significant remodeling that are likely
to contribute to deregulation of VTA DA neurons activity but the
molecular mechanisms and input sources affected by stress are
yet to be elucidated.
VTA DA neurons not only respond to rewarding stimuli but
they can also adapt to aversive and stressful events5. Inputs to the
VTA likely have a role in shaping stress-induced depressive-like
behaviors. For example, a recent study shows that pallidal par-
valbumin neurons adapt their activity in response to chronic
stress, affecting VTA DA excitatory/inhibitory balance38. In
another study, noradrenergic inputs from the locus coeruleus
were shown to promote stress resilience putatively through an
inhibitory mechanism39. The LDTg to VTA pathway has been
studied for its role in reward. For example, direct optogenetic-
mediated activation of LDTg terminals in the VTA is sufficient to
produce conditioned place preference16 and a similar effect is
achieved when the stimulation is restricted to cholinergic term-
inals40. Our study addresses the role of this pathway in stress
processing and demonstrates that aversive encounters with a
dominant male can produce activation of LDTg neurons.
Importantly, chemogenetic activation of the LDTg to VTA
pathway paired with a mild social stress promotes the develop-
ment of depressive-like symptoms and the aberrant increase in
VTA DA neurons activity. These results indicate that LDTg
Fig. 3 Selective chemogenetic inhibition of LDTg cholinergic but not glutamatergic neurons during CSD is sufficient to prevent depressive behaviors and
VTA DA dysregulation. a Bilateral stereotaxic injection of AAV8-hSyn-DIO-hM4-mcherry in the LDTg of ChAT-Cre mice (LDTgChAT-hM4 mice). Confocal
images showing colocalization of mcherry and vesicular acetylcholinesterase transporter (vAChT) Scale bar= 20 µm. Epifluorescence micrograph showing
cholinergic fibers expressing mcherry in close interaction with tyrosine hydroxylase (TH)-positive VTA dopamine neurons. Scale bar= 25 µm. b Social
interaction times in undefeated or defeated LDTgChAT-hM4 mice treated with saline or CNO. Saline-injected defeated mice showed marked social aversion,
whereas CNO injection in the defeated group restored social interaction (number of mice: Naive/Sal= 8; Naive/CNO= 8; CSD/Sal= 18; CSD/CNO= 16).
Interaction treatment × target F(3,46)= 9.62, P= 0.0001; Interaction treatment × stress F(1,46)= 7.99, P < 0.01; repeated-measures two-way ANOVA
followed by Sidak’s comparisons test, asterisks depict NTg vs. Tg comparisons, hash depicts comparisons between saline vs. CNO in the Tg condition; **P
< 0.01, ***P < 0.001, ###P < 0.001. c Inhibition of cholinergic LDTg neurons during CSD prevented increased excitability in VTA DA neurons (number of
cell/mice: Naive/Sal= 11/4; Naive/CNO= 13/4; CSD/Sal= 22/5; CSD/CNO= 18/5). Interaction treatment × current F(18,360)= 4.66, P= 0.0001;
repeated-measures two-way ANOVA followed by Sidak’s comparisons test ***P < 0.001. d Bilateral stereotaxic LDTg injection of AAV8-hSyn-DIO-hM4-
mcherry of Vglut2-Cre mice (LDTgVglut2-hM4 mice). Confocal image shows representative injection site. Confocal image showing glutamatergic fibers
expressing mcherry in close interaction with TH-positive VTA dopamine neurons. Scale bar= 20 µm. e Social interaction times in undefeated or defeated
LDTgVglut2-hM4 mice treated with saline or CNO. Silencing of LDTg glutamatergic neurons by administration of CNO during stress did not prevent the
appearance of social aversion (number of mice: Naive/Sal= 8; Naive/CNO= 9; CSD/Sal= 13; CSD/CNO= 12). Interaction treatment × target F(3,38)=
6.80, P= 0.0009; Interaction treatment × stress F(1,38)= 0.1619, P= 0.6897; repeated-measures two-way ANOVA followed by Sidak’s comparisons test,
asterisks depict NTg vs. Tg comparisons, hash depicts comparisons between saline vs. CNO in the Tg condition; **P < 0.01, ***P < 0.001, ###P < 0.001.
f Patch-clamp recordings in brain slices showed that inhibition of glutamatergic LDTg neurons during CSD did not prevent increased excitability in VTA DA
neurons (number of cell/mice per condition: Naive/Sal= 12/4; Naive/CNO= 14/4; CSD/Sal= 10/5; CSD/CNO= 10/5). Interaction treatment × current F
(6,108)= 0.95, P= 0.466; repeated-measures two-way ANOVA followed by Sidak’s comparisons test ***P < 0.001). All plots depict mean ± SEM
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projections to the mesolimbic pathway not only convey reward-
ing information but also promote alertness in cases of threatening
situations. The LDTg is therefore a more versatile brain structure
than originally thought and should therefore be considered as a
key upstream regulator of the VTA that shapes responses to
salient stimuli, either rewarding or aversive.
There is at present substantial evidence for the involvement of
the DA system in the pathophysiology of depressive-like dis-
orders4. Most preclinical models of depression rely on exposure
to stressful experiences41. Despite inducing shared behavioral
maladaptations, these models are underpinned by different, and
sometimes opposite, cellular changes within the DA system.
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< 0.01. All plots depict mean ± SEM
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Indeed, the two most widely used mouse models of depression,
the unpredictable chronic mild stress (UCMS), and the CSD
produce decreases42,43 or increases8,9,11 in VTA DA neurons’
activity, respectively. Presently, the nature of these discrepancies
is not clear and may be related to differences in the duration of
stress (4–6 weeks for UCMS vs. 10 days for CSD) or protocol
(unpredictable stress vs. contextual association with an aggres-
sor). Importantly, in both models, antidepressant-like effects can
be achieved by phasic optogenetic stimulation of VTA DA
neurons42,44, likely restoring cellular homeostasis and synaptic
flexibility within the system.
In the last decade, technological advances have allowed scientists
to modulate specific cellular pathways in freely moving animals, in
order to dissect brain functions. Among these, chemogenetic
(DREADD) approaches, which combine the use of modified G-
coupled protein receptors that are activated by CNO, have become
increasingly popular18. A recent publication by Gomez et al.45 raised
potential caveats due to the back-metabolism of CNO into clozapine
in vivo. Nevertheless, these findings do not discount our conclusions
since we have shown in non-DREADD-expressing mice that CNO
per se did not impinge on two classical patterns of activity of VTA
DA neurons in vivo (slow, single-spike firing, and fast-bursting
activity) and did not alter behavioral and cellular adaptations to
CSD. Moreover, given that we did not observe stress relief when
inhibiting LDTg glutamatergic neurons further reinforces the
absence of unwanted CNO side effects in this paradigm.
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Fig. 5 CRF-1 receptors expressed in cholinergic LDTg neurons mediate stress-induced depressive-like behaviors and dysregulation of VTA DA neurons.
a Confocal image depicting the LDTg in a ChAT-Cre::tdTtomato (ChATtdTom) mouse coronal section. Visualization of tdTomato-tagged cholinergic
neurons in the electrophysiological set-up during patch-clamp recordings. In current-clamp mode, most cholinergic neurons were silent, but bath
application of the CRF receptor 1 agonist stressin I initiated action potential discharge. This effect was not seen with bath application of the CRF receptor 2
agonist urocortin III (number of cell/mice= 7/3). Quantification of the firing frequency in the absence and presence of stressin I (number of cell/mice=
10/4, **P < 0.01, repeated-measures one-way ANOVA). b To visualize LDTg glutamatergic neurons, Vglut2-Cre mice were injected with an AAV8-hSyn-
DIO-mcherry. Representative current-clamp recordings showing that stressin I (number of cell/mice= 9/3) or urocortin III (number of cell/mice= 9/3)
failed to elicit discharge activity in this neuronal population. c Schematic experimental time line. Wild-type mice were implanted with cannula guides over
the LDTg, allowing for local infusion before each social defeat session. d Local LDTg infusion of the CRF-1 antagonist CP376395 before defeat prevented
the appearance of social aversion (number of mice: Naive/Vehicle= 9; Naive/CP376395= 10; CSD/Vehicle= 10; CSD/ CP376395= 12). Interaction
treatment × target F(3,37)= 6.33, P= 0.0014; Interaction treatment × target F(1,69)= 7.69, P= 0.0002; Interaction treatment × stress F(1,37)= 12.23,
P= 0.0012; repeated-measures two-way ANOVA followed by Sidak’s comparisons test, asterisks depict NTg vs. Tg comparisons, hash depicts
comparisons between saline vs. CNO in the Tg condition; ***P < 0.001, ###P < 0.001. Anatomical coordinates and maps were adjusted from Paxinos48.
e Sucrose preference was absent in saline-treated defeated mice, but infusion of CP376395 in the LDTg during CSD restored sucrose consumption
(number of mice: Naive/Vehicle= 9; Naive/CP376395= 10; CSD/Vehicle= 10; CSD/CP376395= 11). Interaction treatment × stress F(1,36)= 10.63, P=
0.0024; two-way ANOVA followed by Sidak’s comparisons test ***P < 0.001. f Patch-clamp recordings in brain slices showed that increased excitability to
current injection in VTA DA neurons was observed in saline-treated but not in CP376395-treated mice (number of cell/mice: Naive/Sal= 14/5; Naive/
CP376395= 11/4; CSD/Sal= 14/5; CSD/CP376395= 19/5). Interaction current × treatment F(18,324)= 3.19, P < 0.0001; repeated-measures two-way
ANOVA followed by Sidak’s comparisons test, ***P < 0.001. All plots depict mean ± SEM
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In response to stressful situations, CRF initiates neuroendo-
crine changes to orchestrate rapid bodily responses to ensure
adequate behavioral endpoints23. However, due to the broad
central distribution of CRF receptors, the precise site(s) of action
and the CRF-sensitive cell populations need to be identified. More
than 90% of cholinergic neurons in the LDTg express CRF-R146.
In accordance, we show here that acute activation of CRF-R1, but
not CRF-R2, markedly increased firing of cholinergic LDTg
neurons. This is likely to be the molecular event by which chronic
stress triggers hyperactivity of cholinergic LDTg neurons. Indeed,
we report that locally antagonizing CRF-R1 in the LDTg is suf-
ficient to reverse cellular and behavioral marks of stress. Novel
therapies involving modulation of brain pathways are showing
encouraging results so far47. However, future advances in these
therapies will rely on accurate identification of cell-to-cell mis-
communication within delineated neural circuits, and its invol-
vement in pathological mental states. Our data point to a
dysregulation of a tegmental cholinergic pathway arising to the
VTA as a cardinal contributor to stress-induced depressive-like
behaviors (Fig. 6). This imbalance could be targeted by either
pharmacological antagonism to CRF receptors or, in the future,
with novel selective techniques of brain stimulation.
Methods
Animals. All procedures were in accordance with the recommendations of the
European Commission (2010/63/EU) for care and use of laboratory animals, and
approved by the French National Ethical Committee. We used only male C57BL/6J
(Janvier Labs, France), choline acetyltransferase ChAT-IRES-Cre Knock-In mice
(ChAT-Cre mice, The Jackson Laboratory, stock number: 006410) and vglut2-Cre
mice20. To specifically label cholinergic neurons, ChAT-Cre mice were crossed
with tdTomato reporter line (The Jackson Laboratory, stock number 007909).
Experimental transgenic animals were heterozygous and backcrossed on a C57BL/
6J background.
Reagents. Clozapine N-oxyde was purchased from Enzo Life (France), Stressin I,
mecamylamine and CP376395 from Tocris Cookson (UK), Urocortin III from
Sigma-Aldrich (France), and Xylazine/Ketamine from Centravet (France). All
drugs for in vivo administration were diluted in saline (0.9% NaCl). For bath
application of drugs on brain slices, dilution was done in aCSF (artificial cere-
brospinal fluid).
Stereotaxic injections and cannula implantation. Stereotaxic injections were
performed using a stereotaxic frame (Kopf Instruments) under general anesthesia
with xylaizne and ketamine (10 mg/kg and 150 mg/kg, respectively). Anatomical
coordinates and maps were adjusted from Paxinos48. The injection rate was set at
100 nl/min. To identify LDTg neurons projecting to the VTA, mice (5 weeks old)
were injected with green fluorescent retrobeads (200 nl/site; LumaFluor, Inc.)
bilaterally in the VTA (AP:− 3.2 mm, ML: ± 0.6 mm, DV:− 3.7 mm from the
bregma). AAV8-hSyn-hM4D-mCherry and hSyn-DIO-hM4D-mCherry (titration
1012 particles/ml) were purchased from the U.N.C. (University of North Carolina,
USA) vector core facility and bilaterally injected (300 nl/site) in the LDTg (ante-
roposterior AP:− 4.7 mm, mediolateral ML: ± 0.5 mm, dorsoventral DV:− 3.6 mm
from the bregma) of either WT, ChAT-Cre, or Vglut2-Cre mice (5 weeks old).
Animals were given a 3 weeks’ recovery period to allow sufficient viral expression.
For projection-specific manipulation, WT mice (5 weeks old) were injected with
CAV-2-Cre (200 nl/site) in the VTA and with hSyn-DIO-hM3D-mCherry (300 nl/
site) in the LDTg (hereafter named LDTghM3→VTA mice). We thank E.J. Kremer
and the Plateforme de Vectorologie de Montpellier for providing CAV-2-Cre. Two
weeks later, LDTghM3→VTA mice were implanted with double-guide cannulas
above the VTA for local injections of vehicle or mecamylamine. Double-guide
cannulas (ref. C235G, Plastic One), containing dummies (ref. C235DC, Plastic
One) and protected by a dust cap (ref 303DC, Plastic One) were placed 1 mm
above the VTA (AP:− 3.2 mm, ML: ± 0.6 mm, DV: – 3.7 mm from the bregma)
and fixed to the skull with four screws and dental cement. LDTghM3→VTA mice
were allowed to recover for a minimum of 1 week. To target the VTA, cannulas
were inserted through the guides to allow drug delivery at DV:− 4.7 mm.
For bilateral drug injections in freely moving mice of CP376395, double-guide
cannulas containing dummies and protected by a dust cap were placed 1 mm above
the LDTg (AP:− 4.7 mm, ML: ± 0.5 mm, DV:− 2.6 mm from the bregma) of
7 weeks old WT mice and fixed to the skull with four screws and dental cement.
Mice were allowed to recover for a minimum of 1 week. To target the LDTg,
cannulas were inserted through the guides to allow drug delivery at DV:− 3.6 mm.
Drugs or vehicle were injected at flow rate of 100 nl/min. Cannulas were left in
place for another 5 min to avoid backflow.
CSD stress and behavioral tests. The CSD stress paradigm was performed as
previously8. WT, transgenic mice, and their respective control littermates were
subjected to 10 consecutive days of social defeat by former CD1 breeder male mice.
Each experimental mouse faced a new CD1 every day and sessions of defeat were
limited to a maximum of 5 min. Mice were then maintained in sensory, but
not physical, contacts with the dominant male through a semi-permeable barrier.
Undefeated mice (Naive) were not confronted with a dominant male but lived in
similar housing conditions, separated by a semi-permeable barrier. For CNO
experiments, CNO (1 mg/kg, i.p.) or saline (10 ml/kg, i.p.) were administered 30
min before each defeat session. Undefeated mice were treated accordingly without
being defeated. For CP376395 experiments, local infusion within the LDTg of
either CP376395 (500 ng/site in a final volume of 300 nl) or saline (300 nl/site) was
done at a rate of 100 nl/min. Cannulas were then left in place for 5 min to prevent
backflow. For CSD mice, confrontation with the CD1 occurred after an additional
2 min period (i.e., 10 min after starting local drug infusion). Naive animals were
returned to their home cage. Cannula placements were confirmed postmortem. All
behavioral tests were performed in drug-free conditions.
Social interaction was performed 24 h after the last defeat (day 11) in a low
luminosity environment (7 ± 2 lux). Experimental mice were exposed to two
consecutive sessions (150 s each) in an open-field containing initially an empty
perforated box (“target−” condition), which was then replaced by a box containing
an unfamiliar CD1 mouse (“target+ ” condition). The time spent in the interaction
zone surrounding the box was recorded and used as an index of social interaction.
Anhedonia was measured in a two-bottles choice procedure for assessing
sucrose preference. Mice were acclimatized to two bottles containing water during
the last 3 days of the CSD paradigm. Following the social interaction test, mice
were allowed to freely drink from a bottle of water or sucrose (0.5%). Bottles were
weighed and rotated daily. Sucrose preference was calculated as a percentage 100 ×
[volume of sucrose consumed/(volume of sucrose+ volume of water consumed)]
and was averaged over a period of 3 days.
Subthreshold social defeat. The substhreshold social defeat paradigm was based
on Morel et al.21.
LDTghM3→VTA mice received locally vehicle (saline 300 nl/site) or
mecamylamine (1 μg in 300 nl/site)49 in the VTA with the same technical details as
described above for CP376395 experiments. LDTghM3→VTA mice were then
individually introduced into a CD1 cage for 2 min of social defeat. Following this,
LDTghM3→VTA mice received a single saline (10 ml/kg) or CNO (1 mg/ml)
injection and were maintained with the CD1 mice separated through a partition for
20 min. The social defeat was repeated once and mice assessed in the social
interaction test approximately 24 h later as described for the CSD paradigm. For
electrophysiological recordings, LDTghM3→VTA mice were treated accordingly but
received acute saline (10 ml/kg) or mecamylamine (1 mg/kg) i.p. 10 min before the
first SubSD episode.
To selectively activate LDTg cholinergic terminals in the VTA, guides were
placed bilaterally above the VTA of LDTgChAT-hM3 mice to locally infuse CNO.
Local CNO infusion has been recently used for remote control of terminals
activity50,51. LDTgChAT-hM3 mice were submitted to SubSD as described above.
Immediately after the first session of brief social defeat, CNO (10 μM; 300 nl) or
vehicle were infused at a rate of 100 nl/min, while mice were still facing the CD1
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Fig. 6 Schematic model of the findings. In naive conditions, LDTg excitatory
projections regulate the firing and bursting activity of VTA DA neurons.
Chronic social defeat (CSD) increases the excitability of LDTg cholinergic
and glutamatergic neurons that project to the VTA. Enhanced acetylcholine
release increases VTA DA firing via direct activation of neuronal
acetylcholine nicotinic receptors, but also by enhancing glutamatergic
release via presynaptic modulation. CRF binds to CRF-1 receptors in
cholinergic but not glutamatergic neurons, to promote firing in response to
stress. The mechanisms by which LDTg glutamatergic neurons increase
excitability after CSD are not clear, but may involve local cholinergic
innervation, direct stress-related signaling, or others inputs to LDTg
glutamatergic neurons
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mouse through the partition preventing physical contacts. Cannulas were left in
place for 5 min and mice remained facing the CD1 for another 11 min (i.e., total
time of visual and olfactory contacts of 20 min) before entering the second brief
social defeat session. Mice were then returned to their home cage and tested for
social interaction 24 h later.
In vitro patch-clamp recordings. Mice were anesthetized (Ketamine 150 mg/kg/
Xylazine 10 mg/kg) and transcardially perfused with aCSF for slice preparation on
days 11–14. For VTA recordings, horizontal 250 μm slices were obtained in bub-
bled ice-cold 95% O2/5% CO2 aCSF containing (in mM): KCl 2.5, NaH2PO4 1.25,
MgSO4 10, CaCl2 0.5, glucose 11, sucrose 234, NaHCO3 26. Slices were then
incubated in aCSF containing (in mM): NaCl 119, KCl 2.5, NaH2PO4 1.25, MgSO4
1.3, CaCl2 2.5, NaHCO3 26, glucose 11, at 37 °C for 1 h, and then kept at room
temperature. For LDTg recordings, coronal 250 μm slices were obtained using the
same solutions but recovery at 37 °C lasted 15 min.
Slices were transferred and kept at 32–34 °C in a recording chamber superfused
with 2.5 ml/min aCSF. Visualized whole-cell voltage-clamp or current-clamp
recording techniques were used to measure synaptic responses or excitability,
respectively, using an upright microscope (Olympus France). Putative DA neurons
were recorded in the lateral VTA and identified using common criteria such as
localization, cell body size, broad action potential, and large Ih current52. We
compared the profile of putative VTA DA neurons with those recorded using the
DA reporter mouse line PITX3-GFP53 yielding identical profiles (Supplementary
Fig. 6). As reported, this method might introduce bias and neglect VTA DA
neurons with short action potentials54; however, previous results have shown that
chronic social stress-induced depressive behaviors is mostly associated with
maladaptations in DA neurons with broad spikes44,55, which are more abundant in
the lateral part of the VTA56.
Current-clamp experiments were obtained using a Multiclamp 700B (Molecular
Devices, Sunnyvale, CA). Signals were collected and stored using a Digidata 1440 A
converter and pCLAMP 10.2 software (Molecular Devices, CA). In all cases, access
resistance was monitored by a step of − 10 mV (0.1 Hz) and experiments were
discarded if the access resistance increased more than 20%. Internal solution
contained (in mM): K-D-gluconate 135, NaCl 5, MgCl2 2, HEPES 10, EGTA 0.5,
MgATP 2, NaGTP 0.4. Depolarizing (0–300 pA) or hyperpolarizing (0–450 pA)
800 ms current steps were used to assess excitability and membrane properties of
LDTg and VTA neurons.
AMPA-R/NMDA-R ratio was assessed in voltage-clamp mode using an internal
solution containing (in mM) 130 CsCl, 4 NaCl, 2 MgCl2, 1.1 EGTA, 5 HEPES, 2
Na2ATP, 5 sodium creatine phosphate, 0.6 Na3GTP, and 0.1 spermine. Synaptic
currents were evoked by stimuli (60 μs) at 0.1 Hz through a glass pipette placed
200 μm from the patched neurons. Evoked-EPSCs were obtained at V=+ 40 mV
in the absence and presence of the NMDA-R antagonist APV as previously
described21. In all cases, offline analyses were performed using Clampfit 10.2 (Axon
Instruments, USA) and Prism (Graphpad, USA).
In vivo electrophysiological recordings. Single-unit extracellular recordings of
VTA DA cells were performed in anesthetized (chloral hydrate 8%, 400 mg/kg i.p.)
mice as described previously57. Glass electrodes (0.5% sodium acetate) were low-
ered in the VTA according to stereotaxic coordinates (AP:− 3 to− 4 mm; ML: 0.1
to 0.7 mm; DV:− 4 to − 4.8 mm from the bregma). To distinguish DA from non-
DA neurons the following parameters were used: (1) firing rate (between 1 and 10
Hz); (2) action potential duration between the beginning and the negative trough
superior to 1.1 ms. The spontaneous frequency and bursting activity of DA neurons
were compared in naive LDTgGFP and LDTghM4 mice receiving an acute injection
of either saline or CNO. The neuron response to these i.p. injections was deter-
mined by the differences between the maximum of fluctuation on a 3 min period
before and after injection.
Immunohistofluorescence. Mice were deeply anaesthetized with pentobarbital
(Centravet, France) and transcardially perfused with cold phosphate buffer (PB:
0.1 M Na2HPO4/NaH2PO4, pH 7.4), followed by 4% paraformaldehyde (PFA) in
PB 0.1 M. Brains were post-fixed overnight in 4% PFA-PB. Free-floating vibratome
sections (50 μm) were obtained, and correct retrobeads and AAVs injections were
confirmed for each animal.
To specifically label VTA DA neurons, midbrain sections were incubated (30
min) in PBS-BT (phosphate-buffered saline (PBS), 0.5% bovine serum albumin,
0.1% Triton X-100) with 10% normal goat serum (NGS). Sections were then
incubated (4 °C) in PBS-BT, 1% NGS, with mouse anti-tyrosine hydroxylase (1/
1000; Millipore Cat MAB318 lot 2211927) for 36 h. Sections were rinsed in PBS
and incubated (2 h) in goat anti-mouse Alexa488 secondary antibody (1:1000,
Vector Laboratories, Burlingame, CA) in PBS-BT, 1% NGS. Sections were rinsed
with PBS and incubated 5 min with DAPI before mounting with Moviol. Similar
procedures were followed to label c-Fos-, NeuN-, and cholinergic-positive neurons,
using primary anti-c-Fos (1:1000, anti-rabbit, Abcam Cat Ab190289 lot GR266619-
1), anti-NeuN (1:1000; anti-mouse, Millipore Cat MAB377 lot 2279235), anti-
DsRed (1:1000, anti-rabbit, Clontech Cat 632496 lot 632496), anti-mCherry
(1:1000, anti chicken, Abcam Cat ab205402 lot AV4500E), and anti-vesicular
acetylcholine transporter (1:1000, anti-guinea pig, Chemicon Cat AB1588 lot
5281758), respectively. For c-Fos counting, LDTgChAT-mCherry or LDTgVglut-mCherry
mice were killed one hour after an acute social defeat episode (5 min) and brain
sections obtained as described above. Double c-Fos/mCherry
immunohistofluorescence was conducted and images acquired with an Olympus
FV10 confocal microscope. Cell counting was done manually by an experimenter
blind to the conditions using Image J.
Data analysis. Data are presented as means ± SEM and were analyzed using
GraphPad Prism 7. Following a D’Agostino-Pearson's test, determining the nor-
mality of the distributions, statistical analyses were carried out using two-way
analysis of variance with repeated measures when required. Post hoc Sidak’s test
was used when appropriate. Statistical significance was set at P < 0.05.
Data availability
The data that support these findings of this study are available from the corre-
sponding author upon reasonable request.
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